Allworth Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Buy |
|
|||||
|
2025
Q1 | $14.3K | Sell |
|
|||||
|
2024
Q4 | $24.4K | Buy |
|
|||||
|
2024
Q3 | $15.7K | Sell |
|
|||||
|
2024
Q2 | $34.1K | Buy |
|
|||||
|
2024
Q1 | $12.1K | Hold |
|
|||||
|
2023
Q4 | $11.6K | Buy |
|
|||||
|
2023
Q3 | $6.3K | Sell |
|
|||||
|
2023
Q2 | $7.07K | Sell |
|
|||||
|
2023
Q1 | $7.79K | Buy |
|
|||||
|
2022
Q4 | $6.21K | Sell |
|
|||||
|
2022
Q3 | $6K | Buy |
|
|||||
|
2022
Q2 | $3K | Buy |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $9K | Sell |
|
|||||
|
2021
Q3 | $12K | Buy |
|